A Sydney physiotherapy clinic posted a before-and-after photo of a patient’s post-surgery mobility gains last year. Good intentions, real result, patient consented. It still triggered a complaint, because nothing on the post explained why the treatment produced that specific outcome, and AHPRA’s guidance treats an unexplained before-and-after as misleading by default, not by exception.
That’s the pattern behind most AHPRA advertising breaches I see when auditing a new healthcare client’s site: not fraud, not bad faith. A well-meaning attempt to show real results that skipped one required piece of context.
The rule most practices break without realizing it
Testimonials are banned outright for any regulated health service, and the ban is broader than most practice owners assume. AHPRA’s guidelines state advertising “must not use testimonials or purported testimonials” where they touch clinical aspects: symptoms, diagnosis, treatment, outcomes. That covers the five-star Google review a patient left praising their recovery. It covers the Instagram comment you didn’t write but didn’t remove. If it’s on a platform you control and it references a clinical result, you’re expected to take it down, not just avoid writing it yourself.
This is the single biggest gap between how healthcare marketing works in the US, where a glowing patient testimonial is standard conversion-rate-optimization material, and how it has to work in Australia. A US-trained marketer building an Australian practice’s site without knowing this rule will, with complete confidence, build the exact page structure that gets a client in front of a regulator.
Before-and-afters aren’t banned. Unexplained ones are.
Here’s the part that surprises people: AHPRA doesn’t prohibit before-and-after photography. It prohibits before-and-after photography that doesn’t explain itself. The guidance flags images as problematic specifically when “it is not clear how the advertised treatment is responsible for” the change shown, or when the images have been edited or enhanced.
Practically, that means a before-and-after post needs the mechanism stated in plain language next to the image: what was done, over what timeframe, and what typically varies between patients. Skip that explanation and a genuinely honest photo becomes, by the regulator’s own framing, a misleading one.
“Dr” is a protected word, and not the way most industries treat it
Outside healthcare, using an honorific loosely barely registers as a marketing decision. Inside AHPRA’s remit, it’s a compliance line. A dentist using the title “Dr” has to specify the profession on first reference. Not “Dr Jones,” but “Dr Jones (dentist).” The same logic extends to any protected title (nurse, psychologist, and so on) — only practitioners actually registered under that title may use it, and only inside their scope.
Specialist claims sit under the same discipline. “Specialises in” is a phrase that requires approved specialist registration to back it up. Use it loosely on a service page written by someone who’s never checked, and the practice is carrying legal exposure that has nothing to do with how well the page ranks.
Patient stories are where the two failure modes converge
A written patient story does both things at once: it often functions as an implied testimonial, and if it describes a specific personal outcome, AHPRA’s guidance treats it as capable of “creating an unreasonable expectation of beneficial treatment,” since one patient’s result doesn’t generalize. Case-study-style content, the kind that performs extremely well in US healthcare marketing, needs a materially different structure here: outcomes framed as ranges and typical patterns, evidence cited independent of any one patient’s account, and risk information included rather than implied.
None of this means case studies are off the table. It means the ones that work in Australia look more like a clinical evidence summary than a testimonial in a story wrapper, and a marketer who doesn’t know the distinction will keep reaching for the wrong template.
What this actually costs a practice that gets it wrong
Pricing has to show the total cost, not a lead-in figure. “Limited time” language tied to an unsubstantiated health claim is treated as unlawful outright, not just discouraged. Risk disclosure is mandatory wherever a treatment is being promoted; leaving it out is itself the violation, independent of whether the treatment works.
Put together, these aren’t stylistic preferences. They’re the difference between a page a regulator ignores and one that generates a formal notification, and notifications carry real cost: time spent responding, legal review, and for a multi-location group, the same fix repeated across every location page that copied the same non-compliant template.
The actual opportunity here
Compliance isn’t a constraint layered on top of good healthcare marketing in Australia. It’s most of what separates a practice’s marketing partner who understands the market from one who’s porting over playbooks built for the US or UK. A site built around AHPRA’s actual rules — evidence-framed outcomes, accurately titled practitioners, fully disclosed pricing and risk — reads as more credible to both patients and Google than one leaning on testimonials it isn’t allowed to keep up anyway.
If your current site has patient testimonials referencing clinical outcomes, an unexplained before-and-after gallery, or a “Dr” without a specified profession sitting on a service page, that’s not a content polish item for the next redesign cycle. It’s worth checking this week.
Sources: AHPRA — Guidelines for advertising a regulated health service, AHPRA — Summary of the advertising requirements